These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19670701)

  • 1. Expression of selected adhesion molecules in dermatitis herpetiformis and bullous pemphigoid.
    Zebrowska A; Waszczykowska E; Wagrowska-Danilewicz M; Danilewicz M; Erkiert-Polguj A; Pawliczak R; Sysa-Jedrzejowska A
    Pol J Pathol; 2009; 60(1):26-34. PubMed ID: 19670701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of selected integrins and selectins in bullous pemphigoid.
    Zebrowska A; Sysa-Jedrzejowska A; Wagrowska-Danilewicz M; Joss-Wichman E; Erkiert-Polguj A; Waszczykowska E
    Mediators Inflamm; 2007; 2007():31051. PubMed ID: 17515951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid.
    Narbutt J; Waszczykowska E; Lukamowicz J; Sysa-Jedrzejowska A; Kobos J; Zebrowska A
    Pol J Pathol; 2006; 57(2):71-6. PubMed ID: 17019968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wodz K; Sokolowska M; Erkiert-Polguj A; Sysa-Jedrzejowska A; Waszczykowska E; Pawliczak R
    J Dermatol Sci; 2009 Oct; 56(1):58-61. PubMed ID: 19695840
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis.
    Cynkier A; Zebrowska A; Wągrowska-Danilewicz M; Danilewicz M; Erkiert-Polguj A; Stasikowska-Kanicka O; Sysa-Jędrzejowska A; Waszczykowska E
    Pol J Pathol; 2012 Mar; 63(1):31-9. PubMed ID: 22535604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Cynkier A; Sysa-Jedrzejowska A; Waszczykowska E
    Mediators Inflamm; 2013; 2013():967987. PubMed ID: 23970818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
    Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy.
    Dahlman-Ghozlan K; Ortonne JP; Heilborn JD; Stephansson E
    Exp Dermatol; 2004 Feb; 13(2):65-9. PubMed ID: 15009098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis.
    Gornowicz-Porowska J; Bowszyc-Dmochowska M; Dmochowski M
    Autoimmunity; 2012 Feb; 45(1):71-80. PubMed ID: 21916544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of apoptosis in the pathogenesis of dermatitis herpetiformis.
    Caproni M; Torchia D; Antiga E; Degl'Innocenti D; Barletta E; Baroni G; Santucci M; Fabbri P
    Int J Immunopathol Pharmacol; 2005; 18(4):691-9. PubMed ID: 16388717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.
    Zebrowska A; Narbutt J; Sysa-Jedrzejowska A; Kobos J; Waszczykowska E
    Mediators Inflamm; 2005 Dec; 2005(6):373-9. PubMed ID: 16489258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in basement membrane zone components of normal conjunctiva, conjunctiva in glaucoma and normal skin.
    Messmer EM; Valet VM; Kampik A
    Acta Ophthalmol; 2012 Sep; 90(6):e476-81. PubMed ID: 22900849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous pemphigoid and dermatitis herpetiformis: mixed bullous disease or coexistence of two separate entities?
    Sander HM; Utz MM; Peters MS
    J Cutan Pathol; 1989 Dec; 16(6):370-4. PubMed ID: 2693505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular pemphigoid vs dermatitis herpetiformis.
    Jawitz J; Kumar V; Nigra TP; Beutner EH
    J Am Acad Dermatol; 1984 May; 10(5 Pt 2):892-6. PubMed ID: 6373860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adhesion molecules in atopic dermatitis.
    Lugović L; Cupić H; Lipozencić J; Jakić-Razumović J
    Acta Dermatovenerol Croat; 2006; 14(1):2-7. PubMed ID: 16603095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid.
    Inaoki M; Echigo T; Hayashi H; Nagaoka T; Hasegawa M; Takehara K; Fujimoto W; Tedder TF; Sato S
    J Autoimmun; 2006 Nov; 27(3):196-202. PubMed ID: 17055225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.
    Antiga E; Quaglino P; Pierini I; Volpi W; Lami G; Bianchi B; Del Bianco E; Renzi D; Baroni G; Novelli M; Ponti R; Papini M; Di Lollo S; Calabrò AS; Fabbri P; Caproni M
    J Dermatol Sci; 2015 Jan; 77(1):54-62. PubMed ID: 25465638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid.
    Blenkinsopp WK; Haffenden GP; Fry L; Leonard JN
    Am J Dermatopathol; 1983 Dec; 5(6):547-54. PubMed ID: 6364874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant immunohistochemical characteristics of pemphigoid and dermatitis herpetiformis in a patient with atypical bullous dermatosis.
    de Jong MC; van der Meer JB; de Nijs JA; van der Putte SC
    Acta Derm Venereol; 1983; 63(6):476-82. PubMed ID: 6198835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.
    Juczynska K; Wozniacka A; Waszczykowska E; Danilewicz M; Wagrowska-Danilewicz M; Wieczfinska J; Pawliczak R; Zebrowska A
    Mediators Inflamm; 2017; 2017():6716419. PubMed ID: 29203970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.